Keyphrases
Implantable Defibrillator
100%
Ventricular Arrhythmia
56%
Sudden Cardiac Death
27%
Atrial Fibrillation
23%
Israeli
22%
Type 1 Diabetes Mellitus (T1DM)
22%
Implantable Cardioverter Defibrillator Registry
22%
Primary Prevention
21%
Implantable Cardioverter-defibrillator Shock
20%
Amiodarone
20%
Implanted Cardioverter Defibrillator
19%
Israel
18%
Israeli Arabs
18%
Diabetic Patients
18%
Ethnic Differences
18%
Optic Neuropathy
18%
Dronedarone
18%
Men versus Women
18%
Pacemaker
18%
Gene Panel Sequencing
18%
Ejection Fraction
18%
Ablation Therapy
18%
Sudden Cardiac Death Prevention
18%
Familial Aggregation
18%
Hype
18%
Ischemic Heart
18%
Heart Failure Treatment
18%
Pacemaker Implantation
18%
Genetic Basis
18%
Catheter Ablation
12%
Mapping Method
12%
Nonischemic Cardiomyopathy
10%
Cardiac Disease
9%
Cardiac Resynchronization Therapy
9%
MADIT
9%
Heart Failure
9%
Jews
9%
Vision Loss
9%
Arab Cardiovascular Patients
9%
People of Color
9%
Cumulative Incidence
8%
Structural Heart Disease
8%
Arrhythmia
8%
Risk Factors
7%
Permanent Pacemaker
7%
Comorbidity
6%
Cardiac Hospitalization
6%
Arrhythmia Mechanisms
6%
Treatment Choice
6%
Electrical Storm
6%
Medicine and Dentistry
Implantable Automatic Defibrillator
99%
Ventricular Tachycardia
37%
Congestive Heart Failure
30%
Sudden Cardiac Death
28%
Diabetes Mellitus
24%
Defibrillator
23%
Primary Prevention
20%
Amiodarone
20%
Atrial Fibrillation
19%
Ejection Fraction
19%
Ablation Therapy
18%
Heart Muscle Ischemia
18%
Heart Ventricle Arrhythmia
18%
Dronedarone
18%
Optic Neuropathy
18%
Ethnic Difference
18%
Nonischemic Cardiomyopathy
13%
Population Research
12%
Heart Disease
10%
Visual Impairment
9%
Cumulative Incidence
7%
Cardiac Dysrhythmia
7%
Comorbidity
7%
Device Therapy
6%
Chronic Obstructive Pulmonary Disease
6%
Mortality Rate
6%
Ethnic Group
6%
Cardiac Electrophysiology
6%
Prevalence
6%
Clinical Feature
6%
Deterioration
6%
Cardiac Resynchronization Therapy
5%